Latest filing published 05 Mar 2026 for RAPT Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Mary Ann Gray span 5 companies, the busiest being Dyax Corp, BioAtla, Inc. and RAPT Therapeutics, Inc. We count 18 filings; the first trade dates from 14 January 2016 and the latest from 3 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 5 March 2026, the filings show a transaction in RAPT Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations